Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

Clinical trial NCT06685042 · RECRUITING

Trial details

NCT number: NCT06685042
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic System; Sclerosis ANCA Associated Vasculitis Dermatomyositis Polymyositis

Start date: 2024-11-29
Primary completion: 2025-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.